Pharmacy World and Science

, Volume 15, Issue 2, pp 73–78 | Cite as

Drug-utilization study on Curaçao

  • L. E. Visser
  • M. H. Oosterveld
  • G. I. Vos
  • L. T. W. De Jong-Van den Berg


The drug use on Curaçao was evaluated with the help of the prescription forms of twelve community pharmacies at Curaçao over a period of three months. The emphasis of the study was on three therapeutic groups: the systemic antibiotics, the psycholeptics and the anti-inflammatory and antirheumatic drugs. Within the group of systemic antibiotics broad-spectrum antibiotics were very frequently prescribed compared with the small-spectrum penicillins. The consumption of psycholeptics, particularly benzodiazepines, on Curaçao is remarkably low in comparison with drug utilization data of Denmark and the Netherlands. In contrast, the number of defined daily doses per 1,000 persons per day of antirheumatic drugs is higher compared with data from these two countries. Within the analysed groups, large differences occur between the two most important kinds of insurance,i.c., the poor people (PP) and social insurance bank (SVB) insurance. The PP-insured patients consume in the case of antibiotics and antirheumatic drugs almost twice as many and in the case of psycholeptics even five times as many as the SVB-insured patients do. A few calculations of prices prove that the extra amount of drugs consumed by PP-insured has important financial consequences.


Antibiotics Anti-inflammatory agents Curaçao Drug utilization Netherlands Antilles Psychotropic drugs 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    De Haseth CP. Geneesmiddelinformatie in een CaraÏbische gemeenschap: evaluatie van de Curaçaose situatie [Drug information in an Caribbean community: evaluation of the situation on Curaçao]. Pharm Weekbl 1987;122:333–8.Google Scholar
  2. 2.
    Data about population statistics on the Netherlands Antilles. Willemstad: CBS, 1991.Google Scholar
  3. 3.
    Guidelines for ATC classification. Oslo: WHO Collaborating Centre for Drug Statistics Methodology/Nordic Council on Medicines, 1990.Google Scholar
  4. 4.
    Guidelines for DDD. Oslo: WHO Collaborating Centre for Drug Statistics Methodology/Nordic Council on Medicines, 1990.Google Scholar
  5. 5.
    ATC-index, including DDDs for plain substances. Oslo: WHO Collaborating Centre for Drug Statistics Methodology/Nordic Council on Medicines, 1990.Google Scholar
  6. 6.
    MIMS Caribbean. Vol. 21. Epsom: A.E. Morgan Publications, 1991.Google Scholar
  7. 7.
    Oosterveld MH, Visser LE. Drug use on Curaçao. Analysis of drug delivery in community pharmacies [Report]. Groningen: University of Groningen, 1992.Google Scholar
  8. 8.
    Bright RA, Avorn J, Everitt DE. Medicaid data as a resource for epidemiologic studies: strengths and limitations. J Clin Epidemiol 1989;42:937–45.Google Scholar
  9. 9.
    Nordic Statistics on Medicines 1987–1989. Uppsala: Nordic Council on Medicines, 1992.Google Scholar
  10. 10.
    Middelkoop TB. Guide of registered drugs on the Netherlands Antilles. 3rd ed. Willemstad: Logical Connections, 1991.Google Scholar
  11. 11.
    Leufkens HG, Ameling CB, Hekster YA, Bakker A. Utilization patterns of non-steroidal antiinflammatory drugs in an open Dutch population. Pharm Weekbl [Sci] 1990;12(3):97–103.Google Scholar

Copyright information

© Periodicals Service Company 1993

Authors and Affiliations

  • L. E. Visser
    • 1
  • M. H. Oosterveld
    • 1
  • G. I. Vos
    • 2
  • L. T. W. De Jong-Van den Berg
    • 1
  1. 1.Department of Pharmacology and Pharmacotherapeutics, Section Pharmacy and SocietyUniversity of GroningenAW Groningenthe Netherlands
  2. 2.Bureau of Pharmaceutical AffairsCuraçaoNetherlands Antilles

Personalised recommendations